Pictet Asset Management Holding SA »

Nurix Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $40M 1.8M 22.47
2024-03-31 $11M 727k 14.70

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Nurix Therapeutics

BlackRock
BlackRock
Redmile Group
Deep Track Capital
Baker Bros. Advisors
Vanguard Group
T. Rowe Price Associates
State Street Corporation
T. Rowe Price Investment Management
ARK Investment Management
Soleus Capital Management
Morgan Stanley
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors

View all funds holding Nurix Therapeutics